Shares of Zalicus Inc (NASDAQ:ZLCS), rallied following Epirus Switzerland declared clinical data from a Phase 3 study of BOW015, a biosimilar infliximab, in patients with active rheumatoid arthritis. The research is as a similar trial to evaluate BOW015 to Remicade. BOW015 reached an ACR20 response rate of 89.8%, contrasted to 86.4% for Remicade, in week 16. This figure met the formerly specified statistical endpoint. Zalicus Inc (NASDAQ:ZLCS), weekly performance is 26.21%. On last trading day company shares ended up $1.30. Analysts mean target price for the company is $1.20. Zalicus Inc (NASDAQ:ZLCS), distance from 50-day simple moving average (SMA50) is 19.66%.
Cesca Therapeutics Inc (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, announced that it priced an underwritten public offering of 7.53 million Units, consisting of an aggregate of 7.53 million shares of the Company’s common stock and warrants to purchase 2.26 million shares of the Company’s common stock, at a price of $1.50 per Unit. Cesca Therapeutics Inc (NASDAQ:KOOL), fell 17.51% in last trading session and ended the day on $1.46. KOOL, Gross Margin is 36.00% and its return on assets is -43.10%. Cesca Therapeutics Inc (NASDAQ:KOOL), quarterly performance is -18.44%.
BioFuel Energy Corp. (NASDAQ:BIOF), announced that it has entered into a definitive agreement (the “Agreement”) with certain affiliates of Greenlight Capital, Inc. (“Greenlight”) and James R. Brickman (“Brickman”) pursuant to which the Company will acquire the equity interests of JBGL Builder Finance LLC and certain subsidiaries of JBGL Capital, LP (collectively, “JBGL”) from Greenlight and Brickman. JBGL is a series of real estate entities involved in the purchase and development of land for residential purposes, construction lending and home building operations. JBGL is currently owned and controlled by Greenlight and Brickman. BioFuel Energy Corp. (NASDAQ:BIOF), shares moved down 6.10% in last trading session and was closed at $6.77, while trading in range of $6.66 – 7.13. BioFuel Energy Corp. (NASDAQ:BIOF), year to date (YTD) performance is 295.91%.
Lakeland Industries, Inc. (NASDAQ:LAKE), a leading global manufacturer of industrial protective clothing for industry, municipalities, healthcare and to first responders on the federal, state and local levels, announced financial results for its fiscal 2015 first quarter ended April 30, 2014. Sales worldwide increased to $23.5M or 8.1% from $21.7M last year. Excluding Brazil, sales increased to $21.8M or 9.1% this year from $20.0M last year. Gross margin worldwide was 30.2%, compared to 28.0% last year. Excluding Brazil, gross margin increased from 29.0% last year to 29.9% this year. Operating expenses worldwide increased by $0.2 million and decreased as a percent of sales to 27.7% from 29.1% last year. Operating expenses for Lakeland worldwide, excluding Brazil, increased by $558,000. SGA as a percent of sales, excluding Brazil, increased from 25.5% to 26.0%. Lakeland Industries, Inc. (NASDAQ:LAKE), ended the last trading day at $7.40. Company weekly volatility is calculated as 3.78% and price to cash ratio as 7.91. Lakeland Industries, Inc. (NASDAQ:LAKE), showed a negative weekly performance of 5.61%.
China Yida Holding Co (NASDAQ:CNYD), major shareholder Pope Investments Ii Llc purchased 65,000 shares of the company’s stock in a transaction dated Wednesday, June 4th. The shares were purchased at an average price of $3.20 per share, with a total value of $208,000.00. Following the acquisition, the insider now directly owns 678,713 shares of the company’s stock, valued at approximately $2,171,882. China Yida Holding Co (NASDAQ:CNYD), net profit margin is -57.40% and weekly performance is 1.56%. On last trading day company shares ended up $3.25. Analysts mean target price for the company is $11.50. China Yida Holding Co (NASDAQ:CNYD), distance from 50-day simple moving average (SMA50) is -1.49%.